REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ferox S. R. O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Lessors of Other Real Estate Property | Management Consulting Services | Advertising Agencies
Full name: Ferox S. R. O. Profile Updated: July 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ferox S. R. O. is a company in Slovakia, with a head office in Kosice. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on September 28, 2011. The total number of employees is currently 5 - 9 (2025). The latest financial highlights indicate a net sales revenue increase of 0.23% in 2024. Its’ total assets recorded a growth of 12.44%. In 2024, Ferox S. R. O.’s net profit margin increased by 0.98%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Ferox S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Ferox S. R. O. report to view the information.
Registered Capital:
Purchase the Ferox S. R. O. report to view the information.
Financial Auditors:
Purchase the Ferox S. R. O. report to view the information.
Incorporation Date:
September 28, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ferox S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.23%▲
Total operating revenue
0.43%▲
Operating profit (EBIT)
68.14%▲
EBITDA
45.3%▲
Net Profit (Loss) for the Period
69.15%▲
Total assets
12.44%▲
Total equity
19.19%▲
Operating Profit Margin (ROS)
1.23%▲
Net Profit Margin
0.98%▲
Return on Equity (ROE)
4.76%▲
Debt to Equity Ratio
-0.75%▼
Quick Ratio
0.13%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Refarm, S. R. O.
 
Lekaren Polana, S.R.O.
First-Store S.R.O.
 
Lekaren Na Miklovkach, S.R.O.
Park Central, S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo